Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2007-02-05Clinical Trial Update: Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population
This ClinicalTrials.gov update describes the cardiovascular outcomes study in the VA's Rheumatoid Arthritis (VARA) population, but no result…
-
CLINICAL_TRIALS research · 2007-01-04Clinical Trial Update: Hanyang University Medical Center Arthritis Network
Clinical trial update from Hanyang University Medical Center related to rheumatoid arthritis; no status information is provided.
-
FDA approval · 2006-12-20FDA Approved: MELOXICAM — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original ANDA for Meloxicam, manufactured by Unichem Pharmaceuticals (USA), Inc., introducing a generic version of the NSAI…
-
FDA approval · 2006-12-19FDA Approved: DG HEALTH NAPROXEN SODIUM — Supplemental Application (Dolgencorp Inc)
FDA approved a supplemental application for DG Health Naproxen Sodium (naproxen sodium) by Dolgencorp Inc. The action approves the generic p…
-
CLINICAL_TRIALS trial_result · 2006-12-18Clinical Trial Update: Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial) [Phase 3]
Phase 3 trial ORA-Trial evaluating Omegaven in rheumatoid arthritis has completed; the snippet does not provide efficacy results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2006-12-18Clinical Trial Update: Job Adaptation in Patients With Rheumatoid Arthritis
This clinical trial update reports on a completed study examining job adaptation strategies for people with rheumatoid arthritis.
-
FDA approval · 2006-12-12FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for ORENCIA (abatacept) submitted by E.R. Squibb & Sons, L.L.C., indicating an approved update to th…
-
FDA approval · 2006-12-08FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for infliximab submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2006-11-29Clinical Trial Update: Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen [Phase 4]
Phase 4 trial evaluating whether peri-operative ibuprofen prevents ectopic bone-related pain and disability after hip replacement surgery.
-
CLINICAL_TRIALS trial_result · 2006-11-29Clinical Trial Update: Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. [Phase 3]
Phase 3 trial comparing alendronate to alfacalcidol for the prevention of glucocorticoid-induced osteoporosis in rheumatic disease patients …
-
FDA approval · 2006-11-17FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for Etodolac from Taro Pharmaceuticals U.S.A., Inc.
-
FDA approval · 2006-11-17FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for etodolac (generic) submitted by Taro Pharmaceuticals U.S.A., Inc., indicating a supplemental app…
-
CLINICAL_TRIALS research · 2006-10-31Clinical Trial Update: Non Alcoholic Fatty Liver Disease in Rheumatoid Arthritis
This entry provides a clinical-trial update on studying non-alcoholic fatty liver disease in patients with rheumatoid arthritis, sponsored b…
-
FDA approval · 2006-09-26FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., updating the drug's labeling.
-
FDA approval · 2006-09-22FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for tolmetin sodium from Atland Pharmaceuticals, under ANDA074473. This action updates the regulator…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis
A completed NCCIH-supported trial evaluated whether Traditional Chinese Medicine diagnoses align with the herbal prescriptions used for rheu…
-
CLINICAL_TRIALS trial_result · 2006-08-15Clinical Trial Update: Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis [Phase 3]
Clinical trial update for a Phase 3 study of the human anti-TNF monoclonal antibody D2E7 in active rheumatoid arthritis; the study status is…
-
FDA approval · 2006-08-08FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for Tolmetin Sodium from Atland Pharmaceuticals, LLC.
-
FDA approval · 2006-07-28FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited, likely to authorize a new contract manufactur…
-
CLINICAL_TRIALS research · 2006-07-20Clinical Trial Update: Develop Biomarkers for Assessing RA Joint Erosion
A clinical trial update from National Taiwan University Hospital is investigating biomarkers to assess joint erosion in rheumatoid arthritis…
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original application for MELOXICAM, a generic meloxicam product. This marks the first generic approv…
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for MELOXICAM from Zydus Pharmaceuticals USA Inc., granting approval for a generic meloxicam product.
-
FDA approval · 2006-07-19FDA Approved: MELOXICAM — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s generic meloxicam under an original ANDA; the approval covers the standard indications for meloxicam (osteoart…
-
FDA approval · 2006-06-27FDA Approved: CYCLOSPORINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to market a generic cyclosporine product.
-
CLINICAL_TRIALS trial_result · 2006-06-08Clinical Trial Update: Effectiveness of Radon Spa Therapy in Multimodal Rehabilitative Treatment of Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial completed evaluating the effectiveness of radon spa therapy as part of multimodal rehabilitation for rheumatoid arthr…